| scholarly article | Q13442814 |
| P50 | author | Sumit Gupta | Q55094106 |
| Chris Brightling | Q61032080 | ||
| Salman H Siddiqui | Q61108811 | ||
| P2093 | author name string | S Gonem | |
| P2860 | cites work | Asthma control during the year after bronchial thermoplasty. | Q53199152 |
| Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. | Q53461712 | ||
| Differences in airway cytokine profile in severe asthma compared to moderate asthma. | Q53511586 | ||
| Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. | Q53547680 | ||
| Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. | Q55034563 | ||
| Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis | Q55093966 | ||
| Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma | Q55094008 | ||
| Fc RI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells | Q57273058 | ||
| Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma | Q57313580 | ||
| The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma | Q57892223 | ||
| A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma | Q57956064 | ||
| Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up | Q57981845 | ||
| Role of deficient type III interferon-λ production in asthma exacerbations | Q57981862 | ||
| Disordered microbial communities in asthmatic airways | Q21562589 | ||
| Systems medicine: the future of medical genomics and healthcare | Q24288895 | ||
| Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function | Q24319020 | ||
| Genome-wide association study identifies five loci associated with lung function | Q24629653 | ||
| Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function | Q24633262 | ||
| Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins | Q28187049 | ||
| Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness | Q28214089 | ||
| HMGB1 and RAGE in inflammation and cancer | Q28274621 | ||
| A large-scale, consortium-based genomewide association study of asthma | Q28293885 | ||
| Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene | Q28943322 | ||
| Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma | Q29614903 | ||
| Towards a virtual lung: multi-scale, multi-physics modelling of the pulmonary system. | Q30370366 | ||
| Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program | Q30428466 | ||
| Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program | Q30433207 | ||
| Epithelial cell proliferation contributes to airway remodeling in severe asthma | Q30441389 | ||
| IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression | Q30443366 | ||
| Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression | Q31036118 | ||
| Qualitative analysis of high-resolution CT scans in severe asthma | Q33632072 | ||
| Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions | Q33669033 | ||
| A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis | Q33771346 | ||
| Airway wall expression of OX40/OX40L and interleukin-4 in asthma | Q33776845 | ||
| Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma | Q33782854 | ||
| Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology | Q33810699 | ||
| Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. | Q34152095 | ||
| Lebrikizumab treatment in adults with asthma | Q34205683 | ||
| Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. | Q34275321 | ||
| Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes. | Q34289144 | ||
| IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. | Q34535033 | ||
| Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease | Q34629921 | ||
| Thymic stromal lymphopoietin is produced by dendritic cells | Q35118895 | ||
| Transforming growth factor-beta and its role in asthma | Q35172753 | ||
| Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids | Q35534841 | ||
| Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma | Q35535316 | ||
| Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma | Q35537338 | ||
| Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial | Q35716134 | ||
| Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus | Q36403355 | ||
| Clinical applications of induced sputum. | Q36473619 | ||
| Morphological integrity of the bronchial epithelium in mild asthma | Q36587568 | ||
| Meta-analysis of genome-wide linkage studies of asthma and related traits | Q36667639 | ||
| The cytokine network in asthma and chronic obstructive pulmonary disease | Q36955575 | ||
| Discovering susceptibility genes for asthma and allergy | Q37095239 | ||
| Respiratory impedance measurements for assessment of lung mechanics: focus on asthma | Q37200082 | ||
| Probing airway conditions governing ventilation defects in asthma via hyperpolarized MRI image functional modeling | Q37233162 | ||
| A new perspective on concepts of asthma severity and control. | Q37256164 | ||
| Diminished lipoxin biosynthesis in severe asthma | Q37282577 | ||
| The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis | Q37653460 | ||
| Cluster analysis and clinical asthma phenotypes. | Q37711387 | ||
| Mepolizumab and exacerbations of refractory eosinophilic asthma | Q37711391 | ||
| Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis | Q37711393 | ||
| Fibrocyte localization to the airway smooth muscle is a feature of asthma | Q37711395 | ||
| Airway hyperresponsiveness is dissociated from airway wall structural remodeling. | Q37711408 | ||
| Increased sputum and bronchial biopsy IL-13 expression in severe asthma | Q37711413 | ||
| Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection | Q37874666 | ||
| Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease | Q39743331 | ||
| Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation | Q39820641 | ||
| Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases | Q39924958 | ||
| Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. | Q39943916 | ||
| Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. | Q40768651 | ||
| Involvement of the epidermal growth factor receptor in epithelial repair in asthma | Q40870399 | ||
| What can we learn about airway smooth muscle from the company it keeps? | Q42343389 | ||
| Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma | Q42511846 | ||
| Lung function and airway diseases | Q43206615 | ||
| Airway smooth muscle cell proliferation is increased in asthma | Q43704206 | ||
| Factors associated with persistent airflow limitation in severe asthma | Q43732321 | ||
| Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma | Q43787628 | ||
| Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma | Q43962892 | ||
| Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. | Q44247874 | ||
| Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma | Q44460295 | ||
| Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression | Q44467281 | ||
| Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma | Q44534206 | ||
| Risk factors of frequent exacerbations in difficult-to-treat asthma | Q44681336 | ||
| Severe asthma in adults: what are the important questions? | Q44683157 | ||
| Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics | Q44863693 | ||
| Relationship of small airway chymase-positive mast cells and lung function in severe asthma | Q45162669 | ||
| Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound | Q45215082 | ||
| Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma. | Q45923952 | ||
| Mepolizumab for prednisone-dependent asthma with sputum eosinophilia | Q46098864 | ||
| Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial | Q46218994 | ||
| Bronchial matrix and inflammation respond to inhaled steroids despite ongoing allergen exposure in asthma | Q46765352 | ||
| Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide | Q46794686 | ||
| Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. | Q46811030 | ||
| Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma | Q46977245 | ||
| Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction | Q47690991 | ||
| Differences in airway remodeling between subjects with severe and moderate asthma | Q47729207 | ||
| Bronchial dilatation in asthma: relation to clinical and sputum indices | Q47780937 | ||
| Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. | Q47897731 | ||
| Parameters associated with persistent airflow obstruction in chronic severe asthma | Q47946784 | ||
| Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. | Q47979573 | ||
| The outer wall of small airways is a major site of remodeling in fatal asthma | Q48019489 | ||
| T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma | Q48019510 | ||
| Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. | Q50662075 | ||
| Bronchial CD8 cell infiltrate and lung function decline in asthma. | Q50767033 | ||
| High-resolution computed tomography findings in elderly patients with asthma. | Q51223927 | ||
| Peripheral airway involvement in asthma assessed by single-breath SF6 and He washout. | Q51668810 | ||
| Airway structural alterations selectively associated with severe asthma. | Q51690348 | ||
| TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. | Q51695315 | ||
| Mast-cell infiltration of airway smooth muscle in asthma. | Q51715332 | ||
| A biomechanical model of agonist-initiated contraction in the asthmatic airway. | Q51773799 | ||
| P433 | issue | 5 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 638-649 | |
| P577 | publication date | 2011-12-22 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Lung damage and airway remodelling in severe asthma | |
| P478 | volume | 42 |
| Q52682853 | A Quasi-3D compartmental multi-scale approach to detect and quantify diseased regional lung constriction using spirometry data. |
| Q89397425 | A theoretical model of inflammation- and mechanotransduction-driven asthmatic airway remodelling |
| Q33879735 | Acupuncture for asthma: Protocol for a systematic review |
| Q27307729 | Airway and Parenchymal Strains during Bronchoconstriction in the Precision Cut Lung Slice |
| Q45006068 | Airway distensibility by HRCT in asthmatics and COPD with comparable airway obstruction |
| Q51847344 | Allergens, germs and asthma. |
| Q89723811 | Asthma |
| Q38859970 | Autophagy mechanisms in sputum and peripheral blood cells of patients with severe asthma: a new therapeutic target |
| Q34808077 | Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease. |
| Q24197607 | Breathing exercises for adults with asthma |
| Q90651331 | Breathing exercises for adults with asthma |
| Q24185908 | Breathing exercises for children with asthma |
| Q24198936 | Breathing exercises for children with asthma |
| Q34432950 | CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration. |
| Q40533651 | Clinical characteristics of eosinophilic asthma exacerbations |
| Q53688060 | Coupled Immunological and Biomechanical Model of Emphysema Progression. |
| Q28487910 | Curcumin nanoparticles ameliorate ICAM-1 expression in TNF-α-treated lung epithelial cells through p47 (phox) and MAPKs/AP-1 pathways |
| Q38151900 | Developments in the field of allergy in 2012 through the eyes of Clinical & Experimental Allergy |
| Q41813494 | Diffusion lung capacity of carbon monoxide: A novel marker of airways remodeling in asthmatic children? |
| Q51669486 | Effect of Anti-IL-13 Treatment on Airway Dimensions in Severe Asthma. |
| Q36562454 | Inhaled and systemic corticosteroid response in severe asthma assessed by alveolar nitric oxide: a randomized crossover pilot study of add-on therapy |
| Q24198189 | Inspiratory muscle training for asthma |
| Q40185991 | Multi-scale computational models of the airways to unravel the pathophysiological mechanisms in asthma and chronic obstructive pulmonary disease (AirPROM). |
| Q39019280 | New Role of Adult Lung c-kit+ Cells in a Mouse Model of Airway Hyperresponsiveness |
| Q35146898 | No evidence for altered intracellular calcium-handling in airway smooth muscle cells from human subjects with asthma |
| Q39452522 | Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness. |
| Q58125738 | Nociceptin/Orphanin Fq in inflammation and remodeling of the small airways in experimental model of airway hyperresponsiveness |
| Q37084897 | Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma |
| Q59808666 | Non-redundant Functions of IL-6 Produced by Macrophages and Dendritic Cells in Allergic Airway Inflammation |
| Q58576287 | P2X4R promotes airway remodeling by acting on the phenotype switching of bronchial smooth muscle cells in rats |
| Q64270473 | Pleiotropic microRNA-21 in pulmonary remodeling: novel insights for molecular mechanism and present advancements |
| Q30734382 | Polygenic risk and the development and course of asthma: an analysis of data from a four-decade longitudinal study |
| Q26778683 | Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases |
| Q38109606 | Quantitative microscopy of the lung: a problem-based approach. Part 2: stereological parameters and study designs in various diseases of the respiratory tract |
| Q99608766 | Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases |
| Q64122230 | Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation |
| Q85389322 | Small airways, big challenge: measuring the unseen? |
| Q36624292 | Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma |
| Q33945875 | Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability |
| Q61808278 | The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children |
| Q27009449 | The cell biology of asthma |
| Q58466349 | n-3 Fatty acids and asthma |
Search more.